{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:47:04Z","timestamp":1790948824641,"version":"4.1.0"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R56NS095965-01A1"],"award-info":[{"award-number":["R56NS095965-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00702-018-1845-9","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T14:18:24Z","timestamp":1519827504000},"page":"1251-1262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The striatal cholinergic system in l-dopa-induced dyskinesias"],"prefix":"10.1007","volume":"125","author":[{"given":"X. A.","family":"Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bordia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Quik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"key":"1845_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.13715","author":"JJ Aceves Buendia","year":"2017","unstructured":"Aceves Buendia JJ, Tiroshi L, Chiu WH, Goldberg JA (2017) Selective remodeling of glutamatergic transmission to striatal cholinergic interneurons after dopamine depletion. Eur J Neurosci. https:\/\/doi.org\/10.1111\/ejn.13715","journal-title":"Eur J Neurosci"},{"key":"1845_CR2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/mds.1090","volume":"16","author":"JE Ahlskog","year":"2001","unstructured":"Ahlskog JE, Muenter MD (2001) Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16:448\u2013458","journal-title":"Mov Disord"},{"key":"1845_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1152\/physrev.00015.2008","volume":"89","author":"EX Albuquerque","year":"2009","unstructured":"Albuquerque EX, Pereira EF, Alkondon M, Rogers SW (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89:73\u2013120","journal-title":"Physiol Rev"},{"key":"1845_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1172\/JCI90132","volume":"127","author":"C Alcacer","year":"2017","unstructured":"Alcacer C, Andreoli L, Sebastianutto I, Jakobsson J, Fieblinger T, Cenci MA (2017) Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson\u2019s disease therapy. J Clin Invest 127:720\u2013734","journal-title":"J Clin Invest"},{"key":"1845_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.nbd.2017.10.010","volume":"109","author":"P Aldrin-Kirk","year":"2018","unstructured":"Aldrin-Kirk P, Heuer A, Rylander Ottosson D, Davidsson M, Mattsson B, Bjorklund T (2018) Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum. Neurobiol Dis 109:148\u2013162","journal-title":"Neurobiol Dis"},{"key":"1845_CR6","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1152\/jn.1995.73.3.1234","volume":"73","author":"T Aosaki","year":"1995","unstructured":"Aosaki T, Kimura M, Graybiel AM (1995) Temporal and spatial characteristics of tonically active neurons of the primate\u2019s striatum. J Neurophysiol 73:1234\u20131252","journal-title":"J Neurophysiol"},{"key":"1845_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","volume":"132","author":"MF Bastide","year":"2015","unstructured":"Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, De Deurwaerdere P, Ko WK, Simola N, Morelli M, Groc L, Rodriguez MC, Gurevich EV, Quik M, Morari M, Mellone M, Gardoni F, Tronci E, Guehl D, Tison F, Crossman AR, Kang UJ, Steece-Collier K, Fox S, Carta M, Angela Cenci M, Bezard E (2015) Pathophysiology of l-dopa-induced motor and non-motor complications in Parkinson\u2019s disease. Prog Neurobiol 132:96\u2013168","journal-title":"Prog Neurobiol"},{"key":"1845_CR8","doi-asserted-by":"publisher","first-page":"8539","DOI":"10.1523\/JNEUROSCI.18-20-08539.1998","volume":"18","author":"BD Bennett","year":"1998","unstructured":"Bennett BD, Wilson CJ (1998) Synaptic regulation of action potential timing in neostriatal cholinergic interneurons. J Neurosci 18:8539\u20138549","journal-title":"J Neurosci"},{"key":"1845_CR9","doi-asserted-by":"publisher","first-page":"8493","DOI":"10.1523\/JNEUROSCI.20-22-08493.2000","volume":"20","author":"BD Bennett","year":"2000","unstructured":"Bennett BD, Callaway JC, Wilson CJ (2000) Intrinsic membrane properties underlying spontaneous tonic firing in neostriatal cholinergic interneurons. J Neurosci 20:8493\u20138503","journal-title":"J Neurosci"},{"key":"1845_CR10","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1523\/JNEUROSCI.12-09-03591.1992","volume":"12","author":"V Bernard","year":"1992","unstructured":"Bernard V, Normand E, Bloch B (1992) Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J Neurosci 12:3591\u20133600","journal-title":"J Neurosci"},{"key":"1845_CR11","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bbr.2009.12.048","volume":"221","author":"NI Bohnen","year":"2011","unstructured":"Bohnen NI, Albin RL (2011) The cholinergic system and Parkinson disease. Behav Brain Res 221:564\u2013573","journal-title":"Behav Brain Res"},{"key":"1845_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/0306-4522(84)90165-9","volume":"12","author":"JP Bolam","year":"1984","unstructured":"Bolam JP, Wainer BH, Smith AD (1984) Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi-impregnation and electron microscopy. Neuroscience 12:711\u2013718","journal-title":"Neuroscience"},{"key":"1845_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1124\/mol.107.035998","volume":"72","author":"T Bordia","year":"2007","unstructured":"Bordia T, Grady SR, McIntosh JM, Quik M (2007) Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2* nAChRs in mouse, monkey, and Parkinson\u2019s disease striatum. Mol Pharmacol 72:52\u201361","journal-title":"Mol Pharmacol"},{"key":"1845_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1124\/jpet.108.140897","volume":"327","author":"T Bordia","year":"2008","unstructured":"Bordia T, Campos C, Huang L, Quik M (2008) Continuous and intermittent nicotine treatment reduces l-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesias in a rat model of Parkinson\u2019s disease. J Pharmacol Exp Ther 327:239\u2013247","journal-title":"J Pharmacol Exp Ther"},{"key":"1845_CR15","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1124\/jpet.109.162396","volume":"333","author":"T Bordia","year":"2010","unstructured":"Bordia T, Campos C, McIntosh JM, Quik M (2010) Nicotinic receptor-mediated reduction in l-DOPA-induced dyskinesias may occur via desensitization. J Pharmacol Exp Ther 333:929\u2013938","journal-title":"J Pharmacol Exp Ther"},{"key":"1845_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/jnc.12179","volume":"125","author":"T Bordia","year":"2013","unstructured":"Bordia T, McIntosh JM, Quik M (2013) The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine release. J Neurochem 125:291\u2013302","journal-title":"J Neurochem"},{"key":"1845_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuroscience.2015.03.040","volume":"295","author":"T Bordia","year":"2015","unstructured":"Bordia T, McGregor M, McIntosh JM, Drenan RM, Quik M (2015) Evidence for a role for alpha6(*) nAChRs in l-dopa-induced dyskinesias using Parkinsonian alpha6(*) nAChR gain-of-function mice. Neuroscience 295:187\u2013197","journal-title":"Neuroscience"},{"key":"1845_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.nbd.2016.02.019","volume":"91","author":"T Bordia","year":"2016","unstructured":"Bordia T, Perez XA, Heiss J, Zhang D, Quik M (2016) Optogenetic activation of striatal cholinergic interneurons regulates l-dopa-induced dyskinesias. Neurobiol Dis 91:47\u201358","journal-title":"Neurobiol Dis"},{"key":"1845_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1586\/ern.10.70","volume":"10","author":"J Brotchie","year":"2010","unstructured":"Brotchie J (2010) Antidyskinetic actions of amantadine in Parkinson\u2019s disease: are benefits maintained in the long term? Expert Rev Neurother 10:871\u2013873","journal-title":"Expert Rev Neurother"},{"key":"1845_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.celrep.2012.05.011","volume":"2","author":"R Cachope","year":"2012","unstructured":"Cachope R, Mateo Y, Mathur BN, Irving J, Wang HL, Morales M, Lovinger DM, Cheer JF (2012) Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep 2:33\u201341","journal-title":"Cell Rep"},{"key":"1845_CR21","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1111\/j.1460-9568.1998.00348.x","volume":"10","author":"P Calabresi","year":"1998","unstructured":"Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G (1998) Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses. Eur J Neurosci 10:3020\u20133023","journal-title":"Eur J Neurosci"},{"key":"1845_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0166-2236(99)01501-5","volume":"23","author":"P Calabresi","year":"2000","unstructured":"Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G (2000) Acetylcholine-mediated modulation of striatal function. Trends Neurosci 23:120\u2013126","journal-title":"Trends Neurosci"},{"key":"1845_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1152\/jn.00134.2009","volume":"102","author":"L Carrillo-Reid","year":"2009","unstructured":"Carrillo-Reid L, Tecuapetla F, Vautrelle N, Hernandez A, Vergara R, Galarraga E, Bargas J (2009) Muscarinic enhancement of persistent sodium current synchronizes striatal medium spiny neurons. J Neurophysiol 102:682\u2013690","journal-title":"J Neurophysiol"},{"key":"1845_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fneur.2014.00242","volume":"5","author":"MA Cenci","year":"2014","unstructured":"Cenci MA (2014) Presynaptic mechanisms of l-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications. Front Neurol 5:242","journal-title":"Front Neurol"},{"key":"1845_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0079-6123(10)83011-0","volume":"183C","author":"MA Cenci","year":"2010","unstructured":"Cenci MA, Konradi C (2010) Maladaptive striatal plasticity in l-DOPA-induced dyskinesia. Prog Brain Res 183C:209\u2013233","journal-title":"Prog Brain Res"},{"key":"1845_CR26","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1523\/JNEUROSCI.23-21-07820.2003","volume":"23","author":"N Champtiaux","year":"2003","unstructured":"Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, Lena C, Clementi F, Moretti M, Rossi FM, Le Novere N, McIntosh JM, Gardier AM, Changeux JP (2003) Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci 23:7820\u20137829","journal-title":"J Neurosci"},{"key":"1845_CR27","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/0306-4522(95)00507-2","volume":"71","author":"C Contant","year":"1996","unstructured":"Contant C, Umbriaco D, Garcia S, Watkins KC, Descarries L (1996) Ultrastructural characterization of the acetylcholine innervation in adult rat neostriatum. Neuroscience 71:937\u2013947","journal-title":"Neuroscience"},{"key":"1845_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.tips.2004.04.006","volume":"25","author":"F Dajas-Bailador","year":"2004","unstructured":"Dajas-Bailador F, Wonnacott S (2004) Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25:317\u2013324","journal-title":"Trends Pharmacol Sci"},{"key":"1845_CR29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.biopsych.2009.04.025","volume":"66","author":"S Darmopil","year":"2009","unstructured":"Darmopil S, Martin AB, De Diego IR, Ares S, Moratalla R (2009) Genetic inactivation of dopamine D1 but not D2 receptors inhibits l-DOPA-induced dyskinesia and histone activation. Biol Psychiat 66:603\u2013613","journal-title":"Biol Psychiat"},{"key":"1845_CR30","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1523\/JNEUROSCI.5071-13.2014","volume":"34","author":"D Dautan","year":"2014","unstructured":"Dautan D, Huerta-Ocampo I, Witten IB, Deisseroth K, Bolam JP, Gerdjikov T, Mena-Segovia J (2014) A major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem. J Neurosci 34:4509\u20134518","journal-title":"J Neurosci"},{"key":"1845_CR31","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/sj.npp.1301329","volume":"32","author":"M Delfino","year":"2007","unstructured":"Delfino M, Kalisch R, Czisch M, Larramendy C, Ricatti J, Taravini IR, Trenkwalder C, Murer MG, Auer DP, Gershanik OS (2007) Mapping the effects of three dopamine agonists with different dyskinetogenic potential and receptor selectivity using pharmacological functional magnetic resonance imaging. Neuropsychopharmacology 32:1911\u20131921","journal-title":"Neuropsychopharmacology"},{"key":"1845_CR32","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.parkreldis.2014.05.007","volume":"20","author":"T Di Paolo","year":"2014","unstructured":"Di Paolo T, Gregoire L, Feuerbach D, Elbast W, Weiss M, Gomez-Mancilla B (2014) AQW051, a novel and selective nicotinic acetylcholine receptor alpha7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys. Parkinsonism Relat Disord 20:1119\u20131123","journal-title":"Parkinsonism Relat Disord"},{"key":"1845_CR33","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/nn1700","volume":"9","author":"J Ding","year":"2006","unstructured":"Ding J, Guzman JN, Tkatch T, Chen S, Goldberg JA, Ebert PJ, Levitt P, Wilson CJ, Hamm HE, Surmeier DJ (2006) RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci 9:832\u2013842","journal-title":"Nat Neurosci"},{"key":"1845_CR34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neuron.2010.06.017","volume":"67","author":"JB Ding","year":"2010","unstructured":"Ding JB, Guzman JN, Peterson JD, Goldberg JA, Surmeier DJ (2010) Thalamic gating of corticostriatal signaling by cholinergic interneurons. Neuron 67:294\u2013307","journal-title":"Neuron"},{"key":"1845_CR35","first-page":"340","volume":"108","author":"Y Ding","year":"2011","unstructured":"Ding Y, Won L, Britt JP, Lim SA, McGehee DS, Kang UJ (2011) Enhanced striatal cholinergic neuronal activity mediates l-DOPA-induced dyskinesia in parkinsonian mice. Proc Natl Acad Sci USA 108:340\u2013345","journal-title":"Proc Natl Acad Sci USA"},{"key":"1845_CR36","doi-asserted-by":"publisher","first-page":"9877","DOI":"10.1523\/JNEUROSCI.2056-10.2010","volume":"30","author":"RM Drenan","year":"2010","unstructured":"Drenan RM, Grady SR, Steele AD, McKinney S, Patzlaff NE, McIntosh JM, Marks MJ, Miwa JM, Lester HA (2010) Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors. J Neurosci 30:9877\u20139889","journal-title":"J Neurosci"},{"key":"1845_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1001\/archneur.1967.00470260014002","volume":"17","author":"RC Duvoisin","year":"1967","unstructured":"Duvoisin RC (1967) Cholinergic-anticholinergic antagonism in parkinsonism. Arch Neurol 17:124\u2013136","journal-title":"Arch Neurol"},{"key":"1845_CR38","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.biopsych.2014.07.007","volume":"79","author":"M Engeln","year":"2016","unstructured":"Engeln M, Bastide MF, Toulme E, Dehay B, Bourdenx M, Doudnikoff E, Li Q, Gross CE, Boue-Grabot E, Pisani A, Bezard E, Fernagut PO (2016) Selective inactivation of striatal FosB\/DeltaFosB-expressing neurons alleviates l-DOPA-induced dyskinesia. Biol Psychiat 79:354\u2013361","journal-title":"Biol Psychiat"},{"issue":"Suppl 1","key":"1845_CR39","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1038\/sj.bjp.0707510","volume":"153","author":"R Exley","year":"2008","unstructured":"Exley R, Cragg SJ (2008) Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission. Br J Pharmacol 153(Suppl 1):S283\u2013S297","journal-title":"Br J Pharmacol"},{"issue":"7","key":"1845_CR40","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1111\/ejn.12298","volume":"38","author":"R Exley","year":"2013","unstructured":"Exley R, Clements MA, Hartung H, McIntosh JM, Franklin M, Bermudez I, Cragg SJ (2013) Striatal dopamine transmission is reduced after chronic nicotine with a decrease in alpha6-nicotinic receptor control in nucleus accumbens. Eur J Neurosci 38(7):3036\u20133643","journal-title":"Eur J Neurosci"},{"key":"1845_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neures.2007.04.002","volume":"58","author":"E Fino","year":"2007","unstructured":"Fino E, Glowinski J, Venance L (2007) Effects of acute dopamine depletion on the electrophysiological properties of striatal neurons. Neurosci Res 58:305\u2013316","journal-title":"Neurosci Res"},{"key":"1845_CR42","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1523\/JNEUROSCI.4896-13.2014","volume":"34","author":"DJ Foster","year":"2014","unstructured":"Foster DJ, Gentry PR, Lizardi-Ortiz JE, Bridges TM, Wood MR, Niswender CM, Sulzer D, Lindsley CW, Xiang Z, Conn PJ (2014) M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor\u2019s location. J Neurosci 34:3253\u20133262","journal-title":"J Neurosci"},{"key":"1845_CR43","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.neuron.2016.08.017","volume":"91","author":"DJ Foster","year":"2016","unstructured":"Foster DJ, Wilson JM, Remke DH, Mahmood MS, Uddin MJ, Wess J, Patel S, Marnett LJ, Niswender CM, Jones CK, Xiang Z, Lindsley CW, Rook JM, Conn PJ (2016) Antipsychotic-like effects of M4 positive allosteric modulators are mediated by CB2 receptor-dependent inhibition of dopamine release. Neuron 91:1244\u20131252","journal-title":"Neuron"},{"key":"1845_CR44","unstructured":"Mather J, Burdette D, Cebers G, Posener J, Alexander R, Leventer S, Ye N, Poole M, Dunlop J, Fox SH, Ravenscroft P, Johnston TH, Hill MP and Brotchie JM (2014) Potential of AZD1446, a novel nicotinic agonist, for the treatment of l-DOPA-induced dyskinesia in Parkinson\u2019s disease. Soc Neurosci Abstr 43:137.111\/L131"},{"key":"1845_CR45","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1523\/JNEUROSCI.19-09-03629.1999","volume":"19","author":"E Galarraga","year":"1999","unstructured":"Galarraga E, Hernandez-Lopez S, Reyes A, Miranda I, Bermudez-Rattoni F, Vilchis C, Bargas J (1999) Cholinergic modulation of neostriatal output: a functional antagonism between different types of muscarinic receptors. J Neurosci 19:3629\u20133638","journal-title":"J Neurosci"},{"key":"1845_CR46","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2174\/1871527311201070897","volume":"11","author":"JR Garcia-Montes","year":"2012","unstructured":"Garcia-Montes JR, Boronat-Garcia A, Lopez-Colome AM, Bargas J, Guerra-Crespo M, Drucker-Colin R (2012) Is nicotine protective against Parkinson\u2019s disease? An experimental analysis. CNS Neurol Disord: Drug Targets 11:897\u2013906","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"1845_CR47","doi-asserted-by":"publisher","first-page":"14338","DOI":"10.1523\/JNEUROSCI.4223-07.2007","volume":"27","author":"SJ Gold","year":"2007","unstructured":"Gold SJ, Hoang CV, Potts BW, Porras G, Pioli E, Kim KW, Nadjar A, Qin C, LaHoste GJ, Li Q, Bioulac BH, Waugh JL, Gurevich E, Neve RL, Bezard E (2007) RGS9-2 negatively modulates l-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson\u2019s disease. J Neurosci 27:14338\u201314348","journal-title":"J Neurosci"},{"key":"1845_CR48","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.1523\/JNEUROSCI.2734-05.2005","volume":"25","author":"JA Goldberg","year":"2005","unstructured":"Goldberg JA, Wilson CJ (2005) Control of spontaneous firing patterns by the selective coupling of calcium currents to calcium-activated potassium currents in striatal cholinergic interneurons. J Neurosci 25:10230\u201310238","journal-title":"J Neurosci"},{"key":"1845_CR49","doi-asserted-by":"publisher","first-page":"8396","DOI":"10.1523\/JNEUROSCI.5582-08.2009","volume":"29","author":"JA Goldberg","year":"2009","unstructured":"Goldberg JA, Teagarden MA, Foehring RC, Wilson CJ (2009) Nonequilibrium calcium dynamics regulate the autonomous firing pattern of rat striatal cholinergic interneurons. J Neurosci 29:8396\u20138407","journal-title":"J Neurosci"},{"key":"1845_CR50","doi-asserted-by":"crossref","unstructured":"Goldberg JA, Ding JB, Surmeier DJ (2012) Muscarinic modulation of striatal function and circuitry. Handb Exp Pharmacol (208):223\u2013241","DOI":"10.1007\/978-3-642-23274-9_10"},{"key":"1845_CR51","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1471-4159.1992.tb08322.x","volume":"59","author":"S Grady","year":"1992","unstructured":"Grady S, Marks MJ, Wonnacott S, Collins AC (1992) Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848\u2013856","journal-title":"J Neurochem"},{"key":"1845_CR52","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0166-2236(90)90104-I","volume":"13","author":"AM Graybiel","year":"1990","unstructured":"Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244\u2013254","journal-title":"Trends Neurosci"},{"key":"1845_CR53","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12640-009-9041-1","volume":"15","author":"ML Gregorio","year":"2009","unstructured":"Gregorio ML, Wietzikoski EC, Ferro MM, Silveira JL, Vital MA, Da Cunha C (2009) Nicotine induces sensitization of turning behavior in 6-hydroxydopamine lesioned rats. Neurotox Res 15:359\u2013366","journal-title":"Neurotox Res"},{"key":"1845_CR54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0014-2999(99)00482-3","volume":"378","author":"R Grondin","year":"1999","unstructured":"Grondin R, Goulet M, Morissette M, Bedard PJ, Di Paolo T (1999) Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958. Eur J Pharmacol 378:259\u2013263","journal-title":"Eur J Pharmacol"},{"key":"1845_CR55","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neuropharm.2014.09.028","volume":"89","author":"T Hernandez-Flores","year":"2015","unstructured":"Hernandez-Flores T, Hernandez-Gonzalez O, Perez-Ramirez MB, Lara-Gonzalez E, Arias-Garcia MA, Duhne M, Perez-Burgos A, Prieto GA, Figueroa A, Galarraga E, Bargas J (2015) Modulation of direct pathway striatal projection neurons by muscarinic M(4)-type receptors. Neuropharmacology 89:232\u2013244","journal-title":"Neuropharmacology"},{"key":"1845_CR56","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1523\/JNEUROSCI.14-05-03351.1994","volume":"14","author":"SM Hersch","year":"1994","unstructured":"Hersch SM, Gutekunst CA, Rees HD, Heilman CJ, Levey AI (1994) Distribution of m1\u2013m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies. J Neurosci 14:3351\u20133363","journal-title":"J Neurosci"},{"key":"1845_CR57","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/jnc.12751","volume":"130","author":"R Heumann","year":"2014","unstructured":"Heumann R, Moratalla R, Herrero MT, Chakrabarty K, Drucker-Colin R, Garcia-Montes JR, Simola N, Morelli M (2014) Dyskinesia in Parkinson\u2019s disease: mechanisms and current non-pharmacological interventions. J Neurochem 130:472\u2013489","journal-title":"J Neurochem"},{"key":"1845_CR58","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1523\/JNEUROSCI.15-01-00458.1995","volume":"15","author":"AR Howe","year":"1995","unstructured":"Howe AR, Surmeier DJ (1995) Muscarinic receptors modulate N-, P-, and l-type Ca2+ currents in rat striatal neurons through parallel pathways. J Neurosci 15:458\u2013469","journal-title":"J Neurosci"},{"key":"1845_CR59","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.neuropharm.2010.12.032","volume":"60","author":"LZ Huang","year":"2011","unstructured":"Huang LZ, Campos C, Ly J, Ivy Carroll F, Quik M (2011a) Nicotinic receptor agonists decrease l-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats. Neuropharmacology 60:861\u2013868","journal-title":"Neuropharmacology"},{"key":"1845_CR60","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1124\/jpet.111.182949","volume":"338","author":"LZ Huang","year":"2011","unstructured":"Huang LZ, Grady SR, Quik M (2011b) Nicotine reduces l-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors. J Pharmacol Exp Ther 338:932\u2013941","journal-title":"J Pharmacol Exp Ther"},{"key":"1845_CR61","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1124\/pr.111.005678","volume":"65","author":"P Huot","year":"2013","unstructured":"Huot P, Johnston TH, Koprich JB, Fox SH, Brotchie JM (2013) The pharmacology of l-DOPA-induced dyskinesia in Parkinson\u2019s disease. Pharmacol Rev 65:171\u2013222","journal-title":"Pharmacol Rev"},{"key":"1845_CR62","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.nbd.2015.06.015","volume":"82","author":"KA Jennings","year":"2015","unstructured":"Jennings KA, Platt NJ, Cragg SJ (2015) The impact of a parkinsonian lesion on dynamic striatal dopamine transmission depends on nicotinic receptor activation. Neurobiol Dis 82:262\u2013268","journal-title":"Neurobiol Dis"},{"key":"1845_CR63","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1523\/JNEUROSCI.3843-09.2010","volume":"30","author":"J Jeon","year":"2010","unstructured":"Jeon J, Dencker D, Wortwein G, Woldbye DP, Cui Y, Davis AA, Levey AI, Schutz G, Sager TN, Mork A, Li C, Deng CX, Fink-Jensen A, Wess J (2010) A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors. J Neurosci 30:2396\u20132405","journal-title":"J Neurosci"},{"key":"1845_CR64","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuropharm.2013.06.005","volume":"73","author":"TH Johnston","year":"2013","unstructured":"Johnston TH, Huot P, Fox SH, Koprich JB, Szeliga KT, James JW, Graef JD, Letchworth SR, Jordan KG, Hill MP, Brotchie JM (2013) TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaque. Neuropharmacology 73:337\u2013347","journal-title":"Neuropharmacology"},{"key":"1845_CR65","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1124\/mol.58.2.312","volume":"58","author":"S Kaiser","year":"2000","unstructured":"Kaiser S, Wonnacott S (2000) alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release. Mol Pharmacol 58:312\u2013318","journal-title":"Mol Pharmacol"},{"key":"1845_CR66","unstructured":"Katzenschlager R, Sampaio C, Costa J, Lees A (2003) Anticholinergics for symptomatic management of Parkinson\u2019s disease. Cochrane Database System Rev (2):CD003735"},{"key":"1845_CR67","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1523\/JNEUROSCI.13-11-04908.1993","volume":"13","author":"Y Kawaguchi","year":"1993","unstructured":"Kawaguchi Y (1993) Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum. J Neurosci 13:4908\u20134923","journal-title":"J Neurosci"},{"key":"1845_CR68","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1523\/JNEUROSCI.22-02-00529.2002","volume":"22","author":"T Koos","year":"2002","unstructured":"Koos T, Tepper JM (2002) Dual cholinergic control of fast-spiking interneurons in the neostriatum. J Neurosci 22:529\u2013535","journal-title":"J Neurosci"},{"key":"1845_CR69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/jn.00269.2013","volume":"111","author":"JL Koranda","year":"2014","unstructured":"Koranda JL, Cone JJ, McGehee DS, Roitman MF, Beeler JA, Zhuang X (2014) Nicotinic receptors regulate the dynamic range of dopamine release in vivo. J Neurophysiol 111:103\u2013111","journal-title":"J Neurophysiol"},{"issue":"11","key":"1845_CR70","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1093\/cercor\/bhw252","volume":"26","author":"P Kosillo","year":"2016","unstructured":"Kosillo P, Zhang YF, Threlfell S, Cragg SJ (2016) Cortical control of striatal dopamine transmission via striatal cholinergic interneurons. Cereb Cortex 26(11):4160\u20134169","journal-title":"Cereb Cortex"},{"key":"1845_CR71","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.neuropharm.2012.07.046","volume":"63","author":"M Kuroiwa","year":"2012","unstructured":"Kuroiwa M, Hamada M, Hieda E, Shuto T, Sotogaku N, Flajolet M, Snyder GL, Hendrick JP, Fienberg A, Nishi A (2012) Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine\/DARPP-32 signaling in striatonigral and striatopallidal neurons. Neuropharmacology 63:1248\u20131257","journal-title":"Neuropharmacology"},{"key":"1845_CR72","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbr.2008.06.021","volume":"194","author":"C Larramendy","year":"2008","unstructured":"Larramendy C, Taravini IR, Saborido MD, Ferrario JE, Murer MG, Gershanik OS (2008) Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism. Behav Brain Res 194:44\u201351","journal-title":"Behav Brain Res"},{"key":"1845_CR73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbr.2013.04.018","volume":"255","author":"JD Lenz","year":"2013","unstructured":"Lenz JD, Lobo MK (2013) Optogenetic insights into striatal function and behavior. Behav Brain Res 255:44\u201354","journal-title":"Behav Brain Res"},{"key":"1845_CR74","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fnsyn.2014.00022","volume":"6","author":"SA Lim","year":"2014","unstructured":"Lim SA, Kang UJ, McGehee DS (2014) Striatal cholinergic interneuron regulation and circuit effects. Front Synaptic Neurosci 6:22","journal-title":"Front Synaptic Neurosci"},{"key":"1845_CR75","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1038\/npp.2009.74","volume":"34","author":"HS Lindgren","year":"2009","unstructured":"Lindgren HS, Ohlin KE, Cenci MA (2009) Differential involvement of D1 and D2 dopamine receptors in l-DOPA-induced angiogenic activity in a rat model of Parkinson\u2019s disease. Neuropsychopharmacology 34:2477\u20132488","journal-title":"Neuropsychopharmacology"},{"key":"1845_CR76","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.bcp.2009.06.004","volume":"78","author":"PD Livingstone","year":"2009","unstructured":"Livingstone PD, Wonnacott S (2009) Nicotinic acetylcholine receptors and the ascending dopamine pathways. Biochem Pharmacol 78:744\u2013755","journal-title":"Biochem Pharmacol"},{"key":"1845_CR77","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1113\/jphysiol.2012.241786","volume":"591","author":"R Luo","year":"2013","unstructured":"Luo R, Janssen MJ, Partridge JG, Vicini S (2013) Direct and GABA-mediated indirect effects of nicotinic ACh receptor agonists on striatal neurones. J Physiol 591:203\u2013217","journal-title":"J Physiol"},{"key":"1845_CR78","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neuropharm.2017.03.017","volume":"118","author":"X Lv","year":"2017","unstructured":"Lv X, Dickerson JW, Rook JM, Lindsley CW, Conn PJ, Xiang Z (2017) M1 muscarinic activation induces long-lasting increase in intrinsic excitability of striatal projection neurons. Neuropharmacology 118:209\u2013222","journal-title":"Neuropharmacology"},{"key":"1845_CR79","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1113\/jphysiol.1941.sp003913","volume":"99","author":"FC Macintosh","year":"1941","unstructured":"Macintosh FC (1941) The distribution of acetylcholine in the peripheral and the central nervous system. J Physiol 99:436\u2013442","journal-title":"J Physiol"},{"key":"1845_CR80","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.neuron.2016.06.021","volume":"91","author":"AA Mamaligas","year":"2016","unstructured":"Mamaligas AA, Ford CP (2016) Spontaneous synaptic activation of muscarinic receptors by striatal cholinergic neuron firing. Neuron 91:574\u2013586","journal-title":"Neuron"},{"key":"1845_CR81","doi-asserted-by":"publisher","first-page":"37834","DOI":"10.1038\/srep37834","volume":"6","author":"AA Mamaligas","year":"2016","unstructured":"Mamaligas AA, Cai Y, Ford CP (2016) Nicotinic and opioid receptor regulation of striatal dopamine D2-receptor mediated transmission. Sci Rep 6:37834","journal-title":"Sci Rep"},{"key":"1845_CR82","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1046\/j.0022-3042.2002.00805.x","volume":"80","author":"M Marchi","year":"2002","unstructured":"Marchi M, Risso F, Viola C, Cavazzani P, Raiteri M (2002) Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J Neurochem 80:1071\u20131078","journal-title":"J Neurochem"},{"key":"1845_CR83","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1046\/j.1471-4159.1997.68041511.x","volume":"68","author":"DL Marshall","year":"1997","unstructured":"Marshall DL, Redfern PH, Wonnacott S (1997) Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem 68:1511\u20131519","journal-title":"J Neurochem"},{"key":"1845_CR84","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1254\/jjp.86.429","volume":"86","author":"H Matsubayashi","year":"2001","unstructured":"Matsubayashi H, Amano T, Amano H, Sasa M (2001) Excitation of rat striatal large neurons by dopamine and\/or glutamate released from nerve terminals via presynaptic nicotinic receptor (A4beta2 type) stimulation. Jpn J Pharmacol 86:429\u2013436","journal-title":"Jpn J Pharmacol"},{"key":"1845_CR85","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.celrep.2015.09.034","volume":"13","author":"N Maurice","year":"2015","unstructured":"Maurice N, Liberge M, Jaouen F, Ztaou S, Hanini M, Camon J, Deisseroth K, Amalric M, Kerkerian-Le Goff L, Beurrier C (2015) Striatal cholinergic interneurons control motor behavior and basal ganglia function in experimental parkinsonism. Cell Rep 13:657\u2013666","journal-title":"Cell Rep"},{"key":"1845_CR86","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1124\/mol.105.012773","volume":"68","author":"SE McCallum","year":"2005","unstructured":"McCallum SE, Parameswaran N, Bordia T, McIntosh JM, Grady SR, Quik M (2005) Decrease in alpha3*\/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage. Mol Pharmacol 68:737\u2013746","journal-title":"Mol Pharmacol"},{"key":"1845_CR87","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1471-4159.2005.03610.x","volume":"96","author":"SE McCallum","year":"2006","unstructured":"McCallum SE, Parameswaran N, Perez XA, Bao S, McIntosh JM, Grady SR, Quik M (2006) Compensation in pre-synaptic dopaminergic function following nigrostriatal damage in primates. J Neurochem 96:960\u2013972","journal-title":"J Neurochem"},{"key":"1845_CR88","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1136\/jnnp-2013-305271","volume":"85","author":"A Merola","year":"2014","unstructured":"Merola A, Rizzi L, Zibetti M, Artusi CA, Montanaro E, Angrisano S, Lanotte M, Rizzone MG, Lopiano L (2014) Medical therapy and subthalamic deep brain stimulation in advanced Parkinson\u2019s disease: a different long-term outcome? J Neurol Neurosurg Psychiatry 85:552\u2013559","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1845_CR89","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/cne.903230209","volume":"323","author":"MM Mesulam","year":"1992","unstructured":"Mesulam MM, Mash D, Hersh L, Bothwell M, Geula C (1992) Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus. J Comp Neurol 323:252\u2013268","journal-title":"J Comp Neurol"},{"key":"1845_CR90","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","volume":"56","author":"NS Millar","year":"2009","unstructured":"Millar NS, Gotti C (2009) Diversity of vertebrate nicotinic acetylcholine receptors. Neuropharmacology 56:237\u2013246","journal-title":"Neuropharmacology"},{"key":"1845_CR91","doi-asserted-by":"publisher","first-page":"8772","DOI":"10.1523\/JNEUROSCI.0901-14.2014","volume":"34","author":"AB Nelson","year":"2014","unstructured":"Nelson AB, Bussert TG, Kreitzer AC, Seal RP (2014a) Striatal cholinergic neurotransmission requires VGLUT3. J Neurosci 34:8772\u20138777","journal-title":"J Neurosci"},{"key":"1845_CR92","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuron.2014.01.023","volume":"82","author":"AB Nelson","year":"2014","unstructured":"Nelson AB, Hammack N, Yang CF, Shah NM, Seal RP, Kreitzer AC (2014b) Striatal cholinergic interneurons Drive GABA release from dopamine terminals. Neuron 82:63\u201370","journal-title":"Neuron"},{"key":"1845_CR93","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/mds.25826","volume":"29","author":"H Nishijima","year":"2014","unstructured":"Nishijima H, Suzuki S, Kon T, Funamizu Y, Ueno T, Haga R, Suzuki C, Arai A, Kimura T, Suzuki C, Meguro R, Miki Y, Yamada J, Migita K, Ichinohe N, Ueno S, Baba M, Tomiyama M (2014) Morphologic changes of dendritic spines of striatal neurons in the levodopa-induced dyskinesia model. Mov Disord 29:336\u2013343","journal-title":"Mov Disord"},{"key":"1845_CR94","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1523\/JNEUROSCI.3709-06.2007","volume":"27","author":"P Pakhotin","year":"2007","unstructured":"Pakhotin P, Bracci E (2007) Cholinergic interneurons control the excitatory input to the striatum. J Neurosci 27:391\u2013400","journal-title":"J Neurosci"},{"key":"1845_CR95","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biopsych.2005.05.044","volume":"59","author":"N Pavon","year":"2006","unstructured":"Pavon N, Martin AB, Mendialdua A, Moratalla R (2006) ERK phosphorylation and FosB expression are associated with l-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol Psychiat 59:64\u201374","journal-title":"Biol Psychiat"},{"key":"1845_CR96","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11065-015-9303-z","volume":"25","author":"XA Perez","year":"2015","unstructured":"Perez XA (2015) Preclinical evidence for a role of the nicotinic cholinergic system in Parkinson\u2019s disease. Neuropsychol Rev 25:371\u2013383","journal-title":"Neuropsychol Rev"},{"key":"1845_CR97","first-page":"1","volume":"3","author":"XA Perez","year":"2011","unstructured":"Perez XA, Quik M (2011) Focus on alpha4beta2* and alpha6beta2* nAChRs for Parkinson\u2019s disease therapeutics. Mol Cell Pharmacol 3:1\u20136","journal-title":"Mol Cell Pharmacol"},{"key":"1845_CR98","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1124\/mol.108.048843","volume":"74","author":"XA Perez","year":"2008","unstructured":"Perez XA, Bordia T, McIntosh JM, Grady SR, Quik M (2008) Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function. Mol Pharmacol 74:844\u2013853","journal-title":"Mol Pharmacol"},{"key":"1845_CR99","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1124\/mol.110.067561","volume":"78","author":"XA Perez","year":"2010","unstructured":"Perez XA, Bordia T, McIntosh JM, Quik M (2010) {Alpha}6{beta}2* and {alpha}4{beta}2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson\u2019s disease. Mol Pharmacol 78:971\u2013980","journal-title":"Mol Pharmacol"},{"key":"1845_CR100","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1124\/jpet.112.194084","volume":"342","author":"X Perez","year":"2012","unstructured":"Perez X, Ly J, McIntosh JM, Quik M (2012) Chronic nicotine exposure depresses dopamine release in nonhuman primate nucleus accumbens. J Pharmacol Exp Ther 342:335\u2013344","journal-title":"J Pharmacol Exp Ther"},{"key":"1845_CR101","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/jnc.12442","volume":"127","author":"XA Perez","year":"2013","unstructured":"Perez XA, McIntosh JM, Quik M (2013) Long-term nicotine treatment down-regulates alpha6beta2* nicotinic receptor expression and function in nucleus accumbens. J Neurochem 127:762\u2013771","journal-title":"J Neurochem"},{"issue":"4","key":"1845_CR102","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/mds.26955","volume":"32","author":"XA Perez","year":"2017","unstructured":"Perez XA, Zhang D, Bordia T, Quik M (2017) Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice. Mov Disord 32(4):538\u2013548","journal-title":"Mov Disord"},{"key":"1845_CR103","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1152\/jn.00853.2004","volume":"93","author":"T Perez-Rosello","year":"2005","unstructured":"Perez-Rosello T, Figueroa A, Salgado H, Vilchis C, Tecuapetla F, Guzman JN, Galarraga E, Bargas J (2005) Cholinergic control of firing pattern and neurotransmission in rat neostriatal projection neurons: role of CaV2.1 and CaV2.2 Ca2+ channels. J Neurophysiol 93:2507\u20132519","journal-title":"J Neurophysiol"},{"key":"1845_CR104","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1124\/pr.110.003269","volume":"63","author":"M Quik","year":"2011","unstructured":"Quik M, Wonnacott S (2011) {alpha}6{beta}2* and {alpha}4{beta}2* nicotinic acetylcholine receptors as drug targets for Parkinson\u2019s disease. Pharmacol Rev 63:938\u2013966","journal-title":"Pharmacol Rev"},{"key":"1845_CR105","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1124\/mol.63.5.1169","volume":"63","author":"M Quik","year":"2003","unstructured":"Quik M, Sum JD, Whiteaker P, McCallum SE, Marks MJ, Musachio J, McIntosh JM, Collins AC, Grady SR (2003) Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice. Mol Pharmacol 63:1169\u20131179","journal-title":"Mol Pharmacol"},{"key":"1845_CR106","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1523\/JNEUROSCI.0215-06.2006","volume":"26","author":"M Quik","year":"2006","unstructured":"Quik M, Chen L, Parameswaran N, Xie X, Langston JW, McCallum SE (2006) Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates. J Neurosci 26:4681\u20134689","journal-title":"J Neurosci"},{"key":"1845_CR107","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ana.21203","volume":"62","author":"M Quik","year":"2007","unstructured":"Quik M, Cox H, Parameswaran N, O\u2019Leary K, Langston JW, Di Monte D (2007) Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys. Ann Neurol 62:588\u2013596","journal-title":"Ann Neurol"},{"key":"1845_CR108","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.bcp.2011.06.001","volume":"82","author":"M Quik","year":"2011","unstructured":"Quik M, Perez XA, Grady SR (2011) Role of alpha6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders. Biochem Pharmacol 82:873\u2013882","journal-title":"Biochem Pharmacol"},{"key":"1845_CR109","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.neuropharm.2012.04.029","volume":"63","author":"M Quik","year":"2012","unstructured":"Quik M, Park KM, Hrachova M, Mallela A, Huang LZ, McIntosh JM, Grady SR (2012a) Role for alpha6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice. Neuropharmacology 63:450\u2013459","journal-title":"Neuropharmacology"},{"key":"1845_CR110","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/mds.25028","volume":"27","author":"M Quik","year":"2012","unstructured":"Quik M, Perez XA, Bordia T (2012b) Nicotine as a potential neuroprotective agent for Parkinson\u2019s disease. Mov Disord 27:947\u2013957","journal-title":"Mov Disord"},{"key":"1845_CR111","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuropharm.2013.03.038","volume":"71","author":"M Quik","year":"2013","unstructured":"Quik M, Campos C, Bordia T, Strachan JP, Zhang J, McIntosh JM, Letchworth S, Jordan K (2013a) alpha4beta2 Nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats. Neuropharmacology 71:191\u2013203","journal-title":"Neuropharmacology"},{"key":"1845_CR112","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.bcp.2013.06.027","volume":"86","author":"M Quik","year":"2013","unstructured":"Quik M, Campos C, Grady SR (2013b) Multiple CNS nicotinic receptors mediate l-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice. Biochem Pharmacol 86:1153\u20131162","journal-title":"Biochem Pharmacol"},{"key":"1845_CR113","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.nbd.2012.09.006","volume":"50","author":"M Quik","year":"2013","unstructured":"Quik M, Mallela A, Chin M, McIntosh JM, Perez XA, Bordia T (2013c) Nicotine-mediated improvement in l-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function. Neurobiol Dis 50:30\u201341","journal-title":"Neurobiol Dis"},{"key":"1845_CR114","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/mds.25594","volume":"28","author":"M Quik","year":"2013","unstructured":"Quik M, Mallela A, Ly J, Zhang D (2013d) Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson\u2019s disease. Mov Disord 28:1398\u20131406","journal-title":"Mov Disord"},{"issue":"1","key":"1845_CR115","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pharmthera.2014.05.004","volume":"144","author":"M Quik","year":"2014","unstructured":"Quik M, Zhang D, Perez XA, Bordia T (2014) Role for the nicotinic cholinergic system in movement disorders; therapeutic implications. Pharmacol Ther 144(1):50\u201359","journal-title":"Pharmacol Ther"},{"key":"1845_CR116","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/bs.irn.2015.07.005","volume":"124","author":"M Quik","year":"2015","unstructured":"Quik M, Bordia T, Zhang D, Perez XA (2015a) Nicotine and nicotinic receptor drugs: potential for Parkinson\u2019s disease and drug-induced movement disorders. Int Rev Neurobiol 124:247\u2013271","journal-title":"Int Rev Neurobiol"},{"key":"1845_CR117","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.bcp.2015.06.014","volume":"97","author":"M Quik","year":"2015","unstructured":"Quik M, Zhang D, McGregor M, Bordia T (2015b) Alpha7 nicotinic receptors as therapeutic targets for Parkinson\u2019s disease. Biochem Pharmacol 97:399\u2013407","journal-title":"Biochem Pharmacol"},{"key":"1845_CR118","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1212\/WNL.51.2_Suppl_2.S25","volume":"51","author":"NP Quinn","year":"1998","unstructured":"Quinn NP (1998) Classification of fluctuations in patients with Parkinson\u2019s disease. Neurology 51:S25\u2013S29","journal-title":"Neurology"},{"key":"1845_CR119","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(82)90442-1","volume":"2","author":"N Quinn","year":"1982","unstructured":"Quinn N, Marsden CD, Parkes JD (1982) Complicated response fluctuations in Parkinson\u2019s disease: response to intravenous infusion of levodopa. Lancet 2:412\u2013415","journal-title":"Lancet"},{"key":"1845_CR120","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1152\/jn.1996.76.3.2083","volume":"76","author":"A Raz","year":"1996","unstructured":"Raz A, Feingold A, Zelanskaya V, Vaadia E, Bergman H (1996) Neuronal synchronization of tonically active neurons in the striatum of normal and parkinsonian primates. J Neurophysiol 76:2083\u20132088","journal-title":"J Neurophysiol"},{"issue":"11","key":"1845_CR121","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1038\/npp.2014.121","volume":"39","author":"D Revy","year":"2014","unstructured":"Revy D, Jaouen F, Salin P, Melon C, Chabbert D, Tafi E, Concetta L, Langa F, Amalric M, Kerkerian-Le Goff L, Marie H, Beurrier C (2014) Cellular and Behavioral Outcomes of Dorsal Striatonigral Neuron Ablation: New Insights into Striatal Functions. Neuropsychopharmacology 39(11):2662\u20132672","journal-title":"Neuropsychopharmacology"},{"key":"1845_CR122","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nn1244","volume":"7","author":"ME Rice","year":"2004","unstructured":"Rice ME, Cragg SJ (2004) Nicotine amplifies reward-related dopamine signals in striatum. Nat Neurosci 7:583\u2013584","journal-title":"Nat Neurosci"},{"key":"1845_CR123","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.parkreldis.2014.01.012","volume":"20","author":"MG Rizzone","year":"2014","unstructured":"Rizzone MG, Fasano A, Daniele A, Zibetti M, Merola A, Rizzi L, Piano C, Piccininni C, Romito LM, Lopiano L, Albanese A (2014) Long-term outcome of subthalamic nucleus DBS in Parkinson\u2019s disease: from the advanced phase towards the late stage of the disease? Parkinsonism Relat Disord 20:376\u2013381","journal-title":"Parkinsonism Relat Disord"},{"key":"1845_CR124","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.nbd.2009.03.006","volume":"34","author":"P Salin","year":"2009","unstructured":"Salin P, Lopez IP, Kachidian P, Barroso-Chinea P, Rico AJ, Gomez-Bautista V, Coulon P, Kerkerian-Le Goff L, Lanciego JL (2009) Changes to interneuron-driven striatal microcircuits in a rat model of Parkinson\u2019s disease. Neurobiol Dis 34:545\u2013552","journal-title":"Neurobiol Dis"},{"key":"1845_CR125","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1124\/mol.65.6.1526","volume":"65","author":"O Salminen","year":"2004","unstructured":"Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC, Grady SR (2004) Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 65:1526\u20131535","journal-title":"Mol Pharmacol"},{"key":"1845_CR126","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s40263-014-0205-z","volume":"28","author":"E Schaeffer","year":"2014","unstructured":"Schaeffer E, Pilotto A, Berg D (2014) Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson\u2019s disease. CNS Drugs 28:1155\u20131184","journal-title":"CNS Drugs"},{"key":"1845_CR127","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/nn1972","volume":"10","author":"W Shen","year":"2007","unstructured":"Shen W, Tian X, Day M, Ulrich S, Tkatch T, Nathanson NM, Surmeier DJ (2007) Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons. Nat Neurosci 10:1458\u20131466","journal-title":"Nat Neurosci"},{"key":"1845_CR128","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.neuron.2015.10.039","volume":"88","author":"W Shen","year":"2015","unstructured":"Shen W, Plotkin JL, Francardo V, Ko WK, Xie Z, Li Q, Fieblinger T, Wess J, Neubig RR, Lindsley CW, Conn PJ, Greengard P, Bezard E, Cenci MA, Surmeier DJ (2015) M4 muscarinic receptor signaling ameliorates striatal plasticity deficits in models of l-DOPA-induced dyskinesia. Neuron 88:762\u2013773","journal-title":"Neuron"},{"key":"1845_CR129","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0166-2236(90)90106-K","volume":"13","author":"AD Smith","year":"1990","unstructured":"Smith AD, Bolam JP (1990) The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci 13:259\u2013265","journal-title":"Trends Neurosci"},{"issue":"1","key":"1845_CR130","first-page":"435","volume":"27","author":"O Solis","year":"2015","unstructured":"Solis O, Garcia-Montes JR, Gonzalez-Granillo A, Xu M, Moratalla R (2015) Dopamine D3 receptor modulates l-DOPA-induced dyskinesia by targeting D1 receptor-mediated striatal signaling. Cereb Cortex 27(1):435\u2013446","journal-title":"Cereb Cortex"},{"issue":"11","key":"1845_CR131","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1093\/cercor\/bhw263","volume":"26","author":"LM Suarez","year":"2016","unstructured":"Suarez LM, Solis O, Aguado C, Lujan R, Moratalla R (2016) l-DOPA oppositely regulates synaptic strength and spine morphology in D1 and D2 striatal projection neurons in dyskinesia. Cereb Cortex 26(11):4253\u20134264","journal-title":"Cereb Cortex"},{"key":"1845_CR132","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/(SICI)1098-2396(199803)28:3<212::AID-SYN4>3.0.CO;2-D","volume":"28","author":"H Takahashi","year":"1998","unstructured":"Takahashi H, Takada Y, Nagai N, Urano T, Takada A (1998) Nicotine increases stress-induced serotonin release by stimulating nicotinic acetylcholine receptor in rat striatum. Synapse 28:212\u2013219","journal-title":"Synapse"},{"key":"1845_CR133","first-page":"745947","volume":"2012","author":"N Tambasco","year":"2012","unstructured":"Tambasco N, Simoni S, Marsili E, Sacchini E, Murasecco D, Cardaioli G, Rossi A, Calabresi P (2012) Clinical aspects and management of levodopa-induced dyskinesia. Parkinsons Dis 2012:745947","journal-title":"Parkinsons Dis"},{"key":"1845_CR134","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.pbb.2005.06.013","volume":"81","author":"JL Taylor","year":"2005","unstructured":"Taylor JL, Bishop C, Walker PD (2005) Dopamine D1 and D2 receptor contributions to l-DOPA-induced dyskinesia in the dopamine-depleted rat. Pharmacol Biochem Behav 81:887\u2013893","journal-title":"Pharmacol Biochem Behav"},{"key":"1845_CR135","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1523\/JNEUROSCI.5620-09.2010","volume":"30","author":"S Threlfell","year":"2010","unstructured":"Threlfell S, Clements MA, Khodai T, Pienaar IS, Exley R, Wess J, Cragg SJ (2010) Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J Neurosci 30:3398\u20133408","journal-title":"J Neurosci"},{"key":"1845_CR136","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuron.2012.04.038","volume":"75","author":"S Threlfell","year":"2012","unstructured":"Threlfell S, Lalic T, Platt NJ, Jennings KA, Deisseroth K, Cragg SJ (2012) Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 75:58\u201364","journal-title":"Neuron"},{"key":"1845_CR137","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.celrep.2016.08.016","volume":"16","author":"C Tubert","year":"2016","unstructured":"Tubert C, Taravini IR, Flores-Barrera E, Sanchez GM, Prost MA, Avale ME, Tseng KY, Rela L, Murer MG (2016) Decrease of a current mediated by Kv1.3 channels causes striatal cholinergic interneuron hyperexcitability in experimental parkinsonism. Cell Rep 16:2749\u20132762","journal-title":"Cell Rep"},{"key":"1845_CR138","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0165-3806(98)00012-1","volume":"109","author":"EH van Vulpen","year":"1998","unstructured":"van Vulpen EH, van der Kooy D (1998) Striatal cholinergic interneurons: birthdates predict compartmental localization. Brain Res Dev Brain Res 109:51\u201358","journal-title":"Brain Res Dev Brain Res"},{"key":"1845_CR139","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.neuron.2006.04.010","volume":"50","author":"Z Wang","year":"2006","unstructured":"Wang Z, Kai L, Day M, Ronesi J, Yin HH, Ding J, Tkatch T, Lovinger DM, Surmeier DJ (2006) Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50:443\u2013452","journal-title":"Neuron"},{"key":"1845_CR140","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1038\/ncomms4925","volume":"5","author":"L Wang","year":"2014","unstructured":"Wang L, Shang S, Kang X, Teng S, Zhu F, Liu B, Wu Q, Li M, Liu W, Xu H, Zhou L, Jiao R, Dou H, Zuo P, Zhang X, Zheng L, Wang S, Wang C, Zhou Z (2014) Modulation of dopamine release in the striatum by physiologically relevant levels of nicotine. Nat Commun 5:3925","journal-title":"Nat Commun"},{"key":"1845_CR141","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.biopsych.2006.11.032","volume":"62","author":"JE Westin","year":"2007","unstructured":"Westin JE, Vercammen L, Strome EM, Konradi C, Cenci MA (2007) Spatiotemporal pattern of striatal ERK1\/2 phosphorylation in a rat model of l-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biol Psychiat 62:800\u2013810","journal-title":"Biol Psychiat"},{"key":"1845_CR142","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1152\/jn.00630.2005","volume":"95","author":"CJ Wilson","year":"2006","unstructured":"Wilson CJ, Goldberg JA (2006) Origin of the slow afterhyperpolarization and slow rhythmic bursting in striatal cholinergic interneurons. J Neurophysiol 95:196\u2013204","journal-title":"J Neurophysiol"},{"key":"1845_CR143","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1523\/JNEUROSCI.10-02-00508.1990","volume":"10","author":"CJ Wilson","year":"1990","unstructured":"Wilson CJ, Chang HT, Kitai ST (1990) Firing patterns and synaptic potentials of identified giant aspiny interneurons in the rat neostriatum. J Neurosci 10:508\u2013519","journal-title":"J Neurosci"},{"key":"1845_CR144","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1523\/JNEUROSCI.2888-13.2014","volume":"34","author":"L Won","year":"2014","unstructured":"Won L, Ding Y, Singh P, Kang UJ (2014) Striatal cholinergic cell ablation attenuates l-DOPA induced dyskinesia in Parkinsonian mice. J Neurosci 34:3090\u20133094","journal-title":"J Neurosci"},{"key":"1845_CR145","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0014-2999(00)00005-4","volume":"393","author":"S Wonnacott","year":"2000","unstructured":"Wonnacott S, Kaiser S, Mogg A, Soliakov L, Jones IW (2000) Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. Eur J Pharmacol 393:51\u201358","journal-title":"Eur J Pharmacol"},{"key":"1845_CR146","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0361-9230(81)90004-6","volume":"7","author":"NJ Woolf","year":"1981","unstructured":"Woolf NJ, Butcher LL (1981) Cholinergic neurons in the caudate-putamen complex proper are intrinsically organized: a combined Evans blue and acetylcholinesterase analysis. Brain Res Bull 7:487\u2013507","journal-title":"Brain Res Bull"},{"key":"1845_CR147","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1124\/jpet.111.187856","volume":"340","author":"Z Xiang","year":"2012","unstructured":"Xiang Z, Thompson AD, Jones CK, Lindsley CW, Conn PJ (2012) Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson\u2019s disease. J Pharmacol Exp Ther 340:595\u2013603","journal-title":"J Pharmacol Exp Ther"},{"key":"1845_CR148","doi-asserted-by":"publisher","first-page":"12428","DOI":"10.1523\/JNEUROSCI.2939-09.2009","volume":"29","author":"C Xiao","year":"2009","unstructured":"Xiao C, Nashmi R, McKinney S, Cai H, McIntosh JM, Lester HA (2009) Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J Neurosci 29:12428\u201312439","journal-title":"J Neurosci"},{"key":"1845_CR149","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1523\/JNEUROSCI.16-08-02592.1996","volume":"16","author":"Z Yan","year":"1996","unstructured":"Yan Z, Surmeier DJ (1996) Muscarinic (m2\/m4) receptors reduce N- and P-type Ca2+\u00a0currents in rat neostriatal cholinergic interneurons through a fast, membrane-delimited, G-protein pathway. J Neurosci 16:2592\u20132604","journal-title":"J Neurosci"},{"key":"1845_CR150","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nn1243","volume":"7","author":"H Zhang","year":"2004","unstructured":"Zhang H, Sulzer D (2004) Frequency-dependent modulation of dopamine release by nicotine. Nat Neurosci 7:581\u2013582","journal-title":"Nat Neurosci"},{"key":"1845_CR151","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.1523\/JNEUROSCI.22-15-06347.2002","volume":"22","author":"W Zhang","year":"2002","unstructured":"Zhang W, Yamada M, Gomeza J, Basile AS, Wess J (2002) Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1\u2013M5 muscarinic receptor knock-out mice. J Neurosci 22:6347\u20136352","journal-title":"J Neurosci"},{"key":"1845_CR152","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1124\/mol.109.056317","volume":"76","author":"L Zhang","year":"2009","unstructured":"Zhang L, Doyon WM, Clark JJ, Phillips PE, Dani JA (2009) Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum. Mol Pharmacol 76:396\u2013404","journal-title":"Mol Pharmacol"},{"key":"1845_CR153","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.biopsych.2011.07.024","volume":"71","author":"L Zhang","year":"2012","unstructured":"Zhang L, Dong Y, Doyon WM, Dani JA (2012) Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens. Biol Psychiat 71:184\u2013191","journal-title":"Biol Psychiat"},{"key":"1845_CR154","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1124\/jpet.113.207639","volume":"347","author":"D Zhang","year":"2013","unstructured":"Zhang D, Mallela A, Sohn D, Carroll FI, Bencherif M, Letchworth S, Quik M (2013) Nicotinic receptor agonists reduce l-DOPA-induced dyskinesias in a monkey model of Parkinson\u2019s disease. J Pharmacol Exp Ther 347:225\u2013234","journal-title":"J Pharmacol Exp Ther"},{"key":"1845_CR155","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/mds.25817","volume":"29","author":"D Zhang","year":"2014","unstructured":"Zhang D, Bordia T, McGregor M, McIntosh JM, Decker MW, Quik M (2014a) ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson\u2019s disease. Mov Disord 29:508\u2013517","journal-title":"Mov Disord"},{"key":"1845_CR156","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1124\/jpet.114.216283","volume":"351","author":"D Zhang","year":"2014","unstructured":"Zhang D, McGregor M, Decker MW, Quik M (2014b) The alpha7 nicotinic receptor agonist ABT-107 decreases l-Dopa-induced dyskinesias in parkinsonian monkeys. J Pharmacol Exp Ther 351:25\u201332","journal-title":"J Pharmacol Exp Ther"},{"key":"1845_CR157","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/mds.26453","volume":"30","author":"D Zhang","year":"2015","unstructured":"Zhang D, McGregor M, Bordia T, Perez XA, McIntosh JM, Decker MW, Quik M (2015) alpha7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage. Mov Disord 30:1901\u20131911","journal-title":"Mov Disord"},{"key":"1845_CR158","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/nn769","volume":"4","author":"FM Zhou","year":"2001","unstructured":"Zhou FM, Liang Y, Dani JA (2001) Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 4:1224\u20131229","journal-title":"Nat Neurosci"},{"key":"1845_CR159","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/neu.10150","volume":"53","author":"FM Zhou","year":"2002","unstructured":"Zhou FM, Wilson CJ, Dani JA (2002) Cholinergic interneuron characteristics and nicotinic properties in the striatum. J Neurobiol 53:590\u2013605","journal-title":"J Neurobiol"},{"key":"1845_CR160","doi-asserted-by":"publisher","first-page":"9161","DOI":"10.1523\/JNEUROSCI.0873-16.2016","volume":"36","author":"S Ztaou","year":"2016","unstructured":"Ztaou S, Maurice N, Camon J, Guiraudie-Capraz G, Kerkerian-Le Goff L, Beurrier C, Liberge M, Amalric M (2016) Involvement of striatal cholinergic interneurons and M1 and M4 muscarinic receptors in motor symptoms of Parkinson\u2019s disease. J Neurosci 36:9161\u20139172","journal-title":"J Neurosci"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-018-1845-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1845-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1845-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T17:11:24Z","timestamp":1719853884000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-018-1845-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":160,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1845"],"URL":"https:\/\/doi.org\/10.1007\/s00702-018-1845-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]},"assertion":[{"value":"23 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}